1.11k followers • 30 symbols Watchlist by Yahoo Finance
Find the list of top stocks with the highest short interest. Discover stocks you may want to trade and invest in.
Curated by Yahoo Finance
Follow this list to discover and track stocks with the highest short interest. This list is based on a summary of the consolidated market short interest positions listed on the Nasdaq and NYSE and is released every 2 weeks.
The list includes stocks priced at $1 or more with a three month average daily trading volume in excess of 200,000 shares.
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.How are these weighted?
The stocks in this watchlist are weighted equally.
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|Most Shorted Stocks||+1.73%||-||-||-|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|SABR||Sabre Corporation||14.99||+0.02||+0.13%||4:00 PM EDT||3.89M||8.04M||4.76B|
|FLGT||Fulgent Genetics, Inc.||90.5||+0.08||+0.09%||4:00 PM EDT||708.67k||1.90M||2.62B|
|SRNE||Sorrento Therapeutics, Inc.||7.49||+0.05||+0.67%||4:00 PM EDT||5.76M||15.82M||2.14B|
|BGS||B&G Foods, Inc.||30.07||+0.18||+0.60%||4:00 PM EDT||861.41k||2.07M||1.95B|
|INO||Inovio Pharmaceuticals, Inc.||8.74||-0.27||-3.00%||4:00 PM EDT||8.82M||15.26M||1.82B|
|SKT||Tanger Factory Outlet Centers, Inc.||16.94||+0.01||+0.06%||4:00 PM EDT||2.03M||5.49M||1.70B|
|WKHS||Workhorse Group Inc.||13.23||+1.58||+13.56%||4:00 PM EDT||34.28M||20.57M||1.68B|
|IPOE||Social Capital Hedosophia Holdings Corp. V||16.32||+0.04||+0.25%||4:00 PM EDT||2.03M||6.95M||1.64B|
|HRTX||Heron Therapeutics, Inc.||17.87||+0.14||+0.79%||4:00 PM EDT||1.00M||1.02M||1.63B|
|BLNK||Blink Charging Co.||36.41||+1.25||+3.56%||4:00 PM EDT||2.75M||7.43M||1.53B|
|GPRE||Green Plains Inc.||25.88||+0.19||+0.74%||4:00 PM EDT||2.36M||1.17M||1.16B|
|OMER||Omeros Corporation||18.37||-0.04||-0.22%||4:00 PM EDT||476.68k||736.98k||1.14B|
|PLCE||The Children's Place, Inc.||76.84||-1.02||-1.31%||4:00 PM EDT||220.36k||530.00k||1.13B|
|INSG||Inseego Corp.||8.885||+0.10||+1.08%||4:00 PM EDT||1.71M||4.07M||905.67M|
|ESPR||Esperion Therapeutics, Inc.||27.02||-0.02||-0.07%||4:00 PM EDT||299.60k||743.24k||760.78M|
|KPTI||Karyopharm Therapeutics Inc.||9.71||+0.02||+0.21%||4:00 PM EDT||1.36M||2.53M||728.85M|
|GEO||The GEO Group, Inc.||5.88||+0.12||+2.08%||4:00 PM EDT||6.18M||5.53M||715.18M|
|CVM||CEL-SCI Corporation||17.47||+1.00||+6.07%||4:00 PM EDT||847.37k||1.20M||708.05M|
|KDMN||Kadmon Holdings, Inc.||3.92||-0.02||-0.51%||4:00 PM EDT||2.81M||3.69M||673.52M|
|ICPT||Intercept Pharmaceuticals, Inc.||20.28||-0.27||-1.31%||4:00 PM EDT||5.36M||1.15M||669.56M|
|PETS||PetMed Express, Inc.||31.78||-0.41||-1.27%||4:00 PM EDT||262.74k||812.69k||644.22M|
|VXRT||Vaxart, Inc.||5.35||-0.08||-1.38%||4:00 PM EDT||3.86M||13.83M||630.05M|
|CLVS||Clovis Oncology, Inc.||5.98||-0.12||-1.97%||4:00 PM EDT||3.21M||13.87M||625.09M|
|FUV||Arcimoto, Inc.||11.45||+0.32||+2.88%||4:00 PM EDT||896.32k||2.23M||409.43M|
|FREQ||Frequency Therapeutics, Inc.||9.59||-0.21||-2.14%||4:00 PM EDT||1.02M||1.41M||327.77M|
|BEEM||Beam Global||33.34||-0.92||-2.69%||4:00 PM EDT||258.54k||537.60k||295.65M|
|HTZGQ||Hertz Global Holdings, Inc.||1.73||+0.50||+40.65%||3:59 PM EDT||26.65M||6.91M||270.24M|
|XERS||Xeris Pharmaceuticals, Inc.||3.91||+0.05||+1.30%||4:00 PM EDT||1.89M||2.71M||259.30M|
|LCI||Lannett Company, Inc.||4.76||-0.01||-0.21%||4:00 PM EDT||499.39k||642.41k||197.07M|
|WPG||Washington Prime Group Inc.||2.19||-0.04||-1.79%||4:00 PM EDT||1.04M||2.52M||53.23M|
NEW YORK, April 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Workhorse Group Inc. (NASDAQ: WKHS) between July 7, 2020 and February 23, 2021, inclusive (the “Class Period”), of the important May 7, 2021 lead plaintiff deadline. SO WHAT: If you purchased Workhorse securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Workhorse class action, go http://www.rosenlegal.com/cases-register-2042.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 7, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Workhorse was merely hoping that the USPS was going to select an electric vehicle as its Next Generation Delivery Vehicle, and had no assurance or indication from the USPS that this was the case; (2) Workhorse had concealed the fact that – as revealed by the postmaster general in explaining the ultimate decision not to select an electric vehicle – electrifying the USPS’s entire fleet would be impractical and astronomically expensive; and (3) as a result, defendants’ statements about Workhorse’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Workhorse class action, go http://www.rosenlegal.com/cases-register-2042.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 email@example.com firstname.lastname@example.org email@example.com www.rosenlegal.com
RADNOR, Pa., April 17, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse”) that a securities fraud class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of those who purchased or acquired Workhorse securities between July 7, 2020 and February 23, 2021, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired Workhorse securities during the Class Period may, no later than May 7, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at firstname.lastname@example.org; or click https://www.ktmc.com/workhorse-group-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=workhorse. Workhorse is a technology company engaged in the development and manufacturing of electric delivery vehicles. In 2016, the United States Postal Service (“USPS”) announced the USPS Next Generation Delivery Vehicle (“NGDV”) project, a competitive multiyear acquisition process for replacing approximately 165,000 package delivery vehicles. Workhorse was one of the companies vying for the NGDV contract, which was thought to be worth approximately $6.3 billion. The complaint alleges that throughout the Class Period, the defendants continued to indicate that Workhorse would secure the NGDV contract. However, on February 23, 2021, while the market was open, the USPS issued a press release entitled: U.S. Postal Service Awards Contract to Launch Multi-Billion-Dollar Modernization of Postal Delivery Vehicle Fleet. The press release announced that Oshkosh Defense – not Workhorse – had won the lucrative NGDV contract. The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) Workhorse was merely hoping that USPS was going to select an electric vehicle as its NGDV, and had no assurance or indication from USPS that this was the case; (2) Workhorse had concealed the fact that – as revealed by the postmaster general in explaining the ultimate decision not to select an electric vehicle – electrifying the USPS’s entire fleet would be impractical and astronomically expensive; and (3) as a result, the defendants’ public statements were materially false and/or misleading at all relevant times. Workhorse investors may, no later than May 7, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT: Kessler Topaz Meltzer & Check, LLPJames Maro, Jr., Esq.Adrienne Bell, Esq.280 King of Prussia RoadRadnor, PA 19087(844) 887-9500 (toll free)email@example.com
Shareholders of Fulgent Genetics (NASDAQ: FLGT) have been on quite a ride over the past year. The diagnostics company has subjected investors to both euphoria and despair. COVID-19 ushered in an era of testing that propelled shares to huge gains, and the authorization of vaccines convinced Wall Street the boom was behind us.